Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2020 · 10-Q
Revenue$6.49M$6.49M+161.0% vs Q1 2019 Net Income-$1.84M-$1.84MN/M vs Q1 2019 EPS Diluted-$0.39-$0.39N/M vs Q1 2019 Gross Profit$3,194,143+45.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$2,032,019N/M Free Cash Flowderived-$2,089,475N/M Margins · derivedGross margin49.2%−39.2 pt vs Q1 2019
Operating margin-27.7%−21.3 pt vs Q1 2019
Net margin-28.4%−21.8 pt vs Q1 2019
ended Mar 31, 2020 · filed May 12, 2020 · 42 d after period end